Diaper-embedded urine test device for the screening of urinary tract infections in children: a cohort study.


Journal

BMC pediatrics
ISSN: 1471-2431
Titre abrégé: BMC Pediatr
Pays: England
ID NLM: 100967804

Informations de publication

Date de publication:
11 08 2020
Historique:
received: 27 03 2020
accepted: 05 08 2020
entrez: 13 8 2020
pubmed: 13 8 2020
medline: 15 5 2021
Statut: epublish

Résumé

There is a need for an easy and sensitive method for screening of urinary tract infections in young children. We set out to test whether a novel diaper-embedded urine test device is feasible and reliable in screening for urinary tract infections. This prospective cohort study consisted of young children examined due to a suspected acute urinary tract infection at the Pediatric Emergency Department of the Oulu University Hospital, Finland. We analyzed the same urine samples using three different methods: 1) a diaper-embedded test device applied to the urine pad within the diaper, 2) a urine sample aspirated from the urine pad for the conventional point-of-care dipstick test, and 3) a urine sample aspirated from the urine pad and analyzed in the laboratory with an automated urine chemistry analyzer. The gold standard for confirming urinary tract infection was quantitative bacterial culture. Urine samples were available from 565 children. Bacterial culture confirmed urinary tract infection in 143 children. Sensitivity of the positive leukocyte screening of the diaper-embedded urine test device was 93.1% (95% CI: 87.4-96.8) and that of the point-of-care urine dipstick analysis was 95.4% (90.3-98.3) in those with both tests results available (n = 528). The sensitivity of the positive leukocyte test of the diaper-embedded test device was 91.4% (85.4-95.5) and that of the automated analysis was 88.5% (82.0-93.3) in those with both tests available (n = 547). The time to the test result after urination was immediate for the diaper-embedded test, 1-5 min for point-of-care dipstick, and 30-60 min for laboratory-based automated urine chemistry analyzer. In this prospective study, the diaper-embedded urine test device was an easy and sensitive screening method for UTIs in young children. The main clinical benefit of the diaper-embedded urine test device was that the screening test result was available immediately after urination.

Sections du résumé

BACKGROUND
There is a need for an easy and sensitive method for screening of urinary tract infections in young children. We set out to test whether a novel diaper-embedded urine test device is feasible and reliable in screening for urinary tract infections.
METHODS
This prospective cohort study consisted of young children examined due to a suspected acute urinary tract infection at the Pediatric Emergency Department of the Oulu University Hospital, Finland. We analyzed the same urine samples using three different methods: 1) a diaper-embedded test device applied to the urine pad within the diaper, 2) a urine sample aspirated from the urine pad for the conventional point-of-care dipstick test, and 3) a urine sample aspirated from the urine pad and analyzed in the laboratory with an automated urine chemistry analyzer. The gold standard for confirming urinary tract infection was quantitative bacterial culture.
RESULTS
Urine samples were available from 565 children. Bacterial culture confirmed urinary tract infection in 143 children. Sensitivity of the positive leukocyte screening of the diaper-embedded urine test device was 93.1% (95% CI: 87.4-96.8) and that of the point-of-care urine dipstick analysis was 95.4% (90.3-98.3) in those with both tests results available (n = 528). The sensitivity of the positive leukocyte test of the diaper-embedded test device was 91.4% (85.4-95.5) and that of the automated analysis was 88.5% (82.0-93.3) in those with both tests available (n = 547). The time to the test result after urination was immediate for the diaper-embedded test, 1-5 min for point-of-care dipstick, and 30-60 min for laboratory-based automated urine chemistry analyzer.
CONCLUSIONS
In this prospective study, the diaper-embedded urine test device was an easy and sensitive screening method for UTIs in young children. The main clinical benefit of the diaper-embedded urine test device was that the screening test result was available immediately after urination.

Identifiants

pubmed: 32781982
doi: 10.1186/s12887-020-02277-5
pii: 10.1186/s12887-020-02277-5
pmc: PMC7419204
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

378

Commentaires et corrections

Type : CommentIn

Références

JAMA. 2007 Dec 26;298(24):2895-904
pubmed: 18159059
Swiss Med Wkly. 2012 Apr 05;142:w13560
pubmed: 22481595
J Urol. 2005 Mar;173(3):949-54
pubmed: 15711347
Clin Chim Acta. 2007 Feb;377(1-2):98-102
pubmed: 17049339
Lancet. 1991 Sep 28;338(8770):767-70
pubmed: 1681158
BMJ. 2007 Aug 25;335(7616):395-7
pubmed: 17717369
Eur Urol. 2015 Mar;67(3):546-58
pubmed: 25477258
Br J Gen Pract. 2013 Feb;63(607):e156-64
pubmed: 23561695
Pediatrics. 2014 May;133(5):e1121-7
pubmed: 24777232
BMJ. 2017 Apr 7;357:j1341
pubmed: 28389435
Acta Paediatr. 2010 Apr;99(4):581-4
pubmed: 20055779
Arch Dis Child Educ Pract Ed. 2020 Jun;105(3):164-171
pubmed: 31444213
J Biomed Inform. 2014 Apr;48:193-204
pubmed: 24582925
Arch Dis Child. 2013 Jan;98(1):27-9
pubmed: 23172785
Lancet. 1991 Sep 14;338(8768):674-6
pubmed: 1679482
Pediatrics. 2011 Sep;128(3):595-610
pubmed: 21873693
J Paediatr Child Health. 2017 Oct;53(10):970-975
pubmed: 28618045
Pediatr Nephrol. 2019 Jul;34(7):1283-1288
pubmed: 30895368
Lancet Infect Dis. 2010 Apr;10(4):240-50
pubmed: 20334847
Clin Biochem. 1996 Jun;29(3):217-23
pubmed: 8740507

Auteurs

Niko Paalanne (N)

Department of Pediatrics and Adolescent Medicine, Oulu University Hospital, Oulu, Finland. niko.paalanne@oulu.fi.
PEDEGO Research Unit and Medical Research Centre, University of Oulu, Oulu, Finland. niko.paalanne@oulu.fi.

Lotta Wikstedt (L)

Department of Pediatrics and Adolescent Medicine, Oulu University Hospital, Oulu, Finland.
PEDEGO Research Unit and Medical Research Centre, University of Oulu, Oulu, Finland.

Tytti Pokka (T)

Department of Pediatrics and Adolescent Medicine, Oulu University Hospital, Oulu, Finland.
PEDEGO Research Unit and Medical Research Centre, University of Oulu, Oulu, Finland.

Jarmo Salo (J)

Department of Pediatrics and Adolescent Medicine, Oulu University Hospital, Oulu, Finland.
PEDEGO Research Unit and Medical Research Centre, University of Oulu, Oulu, Finland.

Matti Uhari (M)

Department of Pediatrics and Adolescent Medicine, Oulu University Hospital, Oulu, Finland.
PEDEGO Research Unit and Medical Research Centre, University of Oulu, Oulu, Finland.

Marjo Renko (M)

Department of Pediatrics and Adolescent Medicine, Oulu University Hospital, Oulu, Finland.
PEDEGO Research Unit and Medical Research Centre, University of Oulu, Oulu, Finland.
Department of Pediatrics, University of Eastern Finland and Kuopio University Hospital, Kuopio, Finland.

Terhi Tapiainen (T)

Department of Pediatrics and Adolescent Medicine, Oulu University Hospital, Oulu, Finland.
PEDEGO Research Unit and Medical Research Centre, University of Oulu, Oulu, Finland.
Biocenter Oulu, University of Oulu, Oulu, Finland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH